- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03343249
Adjunctive Smart Phone Based Smoking Cessation Treatment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Research Supporting Study Objectives. Tobacco use is the leading cause of preventable death in the U.S. Over 443,000 deaths per year are attributable to smoking, with the leading causes of smoking-attributable death being cancer, cardiovascular diseases, and respiratory disease. Although the prevalence of smoking has declined to 20.6% among U.S. adults, 31.1% of those living in poverty are currently smoking. Numerous studies have shown that low SES and financial strain are associated with a reduced likelihood of smoking cessation. As such, lung cancer incidence is far greater among those with low education and who are living in poverty, relative to their higher SES counterparts. Although individuals of low SES are just as likely to attempt smoking cessation, they are less likely to succeed. As such, smoking cessation interventions for low SES populations have had limited success (e.g., biologically confirmed 7-day point prevalence abstinence rates of 7-13% at 6-month follow-up. Innovative smoking cessation interventions are needed to help reduce the rate of smoking in socioeconomically disadvantaged populations of smokers.
Ecological Momentary Assessment and Smoking Cessation Treatments. To date, most studies that have examined smoking and smoking cessation in socioeconomically disadvantaged smokers have used focus groups or traditional lab/clinic based assessment methodology. In the latter scenario, study participants arrive at a lab or clinic for their baseline visit and are asked to answer questions about their "average" or "recent" (e.g., over the past 2 weeks) mood, level of stress, and smoking urges. Participants return to the lab/clinic for follow-up visits and are asked to report thoughts, feelings, and activities that occurred weeks or even months earlier (e.g., "How stressed were you when you smoked your first cigarette after your quit date?"). This type of assessment methodology may result in biased and/or inaccurate estimates due to recall biases and errors in memory and only offers a gross understanding of how cessation symptoms effect smoking lapses and relapse. A more nuanced picture of these symptoms may offer important insights that may be used to create or improve cessation interventions for socioeconomically disadvantaged smokers, who face unique and substantial challenges in quitting smoking.
Ecological momentary assessment (EMA), in which handheld devices (e.g., smart phones) are used to capture moment to moment experience, is currently the most accurate way to measure phenomena in real time in natural settings. EMAs are often used to assess individuals at multiple time points throughout a day. Thus, momentary changes in key variables can be tracked and potentially used to initiate novel interventions. EMA research may facilitate a better understanding of the mechanisms involved in successful cessation attempts, those affecting smoking lapses, and those implicated in the transition from lapse to relapse. Although multiple studies have identified momentary predictors of smoking relapse to our knowledge, no studies have used a participant's responses to EMAs to automatically prompt tailored smoking cessation interventions. Using smart phones to detect high relapse risk situations and automatically deliver tailored smoking cessation treatments may help socioeconomically disadvantaged smokers quit.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Participants will be included in the study if they:
- earn a score greater than or equal to 4 on the Short REALM indicating greater than 6th grade English literacy level,
- are willing to quit smoking 7 days from their first visit,
- are greater than or equal to 18 years of age,
- have an expired CO level greater than or equal to 8 ppm suggestive of current smoking,
- are currently smoking greater than or equal to 5 cigarettes per day,
- are willing and able to attend 6 weekly sessions (i.e., week -1, quit day, week +1, week +2, week +3, week +4) and the 12 week follow-up session , and
- have not previously participated in Project PREVAIL [STU 042011-096] at Parkland Hospital. Please note that the Parkland smoking cessation program (usual care) is currently offered in English only.
Exclusion Criteria:
Participants will be excluded from the study if they:
- are unwilling to quit smoking 7 days from their first visit,
- have already quit smoking,
- earn a score less than 4 on the Short REALM indicating less than or equal to 6th grade literacy level,
- produce an expired CO level less than 8 ppm,
- are currently smoking less than 5 cigarettes per day,
- are unwilling or unable to attend 7 assessment sessions,
- are less than 18 years of age, and/or
- have not previously participated in Project PREVAIL [STU 042011-096] at Parkland Hospital. Please note that the Parkland smoking cessation program (usual care) is currently offered in English only.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study Visits
The Short form of the Rapid Estimate of Adult Literacy in Medicine (REALM) will be administered to ensure that all participants are able to read at > sixth grade level. Expired carbon monoxide (CO) will be measured. Assessment: Participants will complete self-report questionnaires; and expired CO, weight, and height will be measured. Participants will be provided with a Samsung Galaxy Light Android smart phone and instructed on how to: 1) use the phone features, 2) complete EMAs, and 3) use the adjunctive Smart-T phone based treatment. Participants will receive 4 random prompts and 1 daily diary prompt during their normal waking hours each day for three consecutive weeks. Random assessments will take approximately 1 min to complete and daily diary assessments will take approximately 5 mins to complete. |
The Samsung Galaxy Light Smart phone uses the Android 4.2 operating system.
The phone has a 4.0 inch (480x800-pixel resolution) touch screen display, a built in microphone, earphone jack, audio speaker, and a rechargeable battery with 12.5 hours of talk time.
The phone has 4G and is Wi-Fi and GPS capable.
Participants navigate through the EMA program and enter data simply by touching the screen, similar to a pen-and-paper questionnaire.
Thus, computer/typing skills are not required.
Participants have the ability to call and receive calls from research staff through the smart phone free of charge.
All phones will be equipped with Global Positioning Systems (GPS) capability.
The smart phones are also equipped with a Secure Digital card to store data as it is collected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking abstinence
Time Frame: 12 weeks
|
Evidence of abstinence from smoking confirmed by questionnaire.
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jennifer Gonzalez, UT southwestern Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SCCC-PSO1Z14
- STU 012014-012 (Other Identifier: UTSouthwestern Medical Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High-Risk Cancer
-
Prisma Health-UpstateRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingHigh-risk Prostate CancerItaly
-
Rabin Medical CenterRecruitingHigh Risk Prostate CancerIsrael
-
BayerRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsNot yet recruiting
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingHigh-risk Non-muscle-invasive Bladder CancerChina
-
Jecho Biopharmaceuticals Co., Ltd.Not yet recruitingHigh Risk Non-muscle Invasive Bladder Cancer
-
Amsterdam UMC, location VUmcPulsecath BV.RecruitingHigh-risk PCI | Coronary Artery Disease Risk HighNetherlands
-
Magenta Medical Ltd.RecruitingHigh-Risk Percutaneous Coronary Intervention (High-risk PCI)United States
-
Radboud University Medical CenterNot yet recruitingHigh Risk Localized Prostate Cancer | Synchronous Metastatic Hormone-Sensitive Prostate Cancer
Clinical Trials on Smart Phone Based Smoking Cessation
-
Mayo ClinicUniversity of California, San Francisco; University of Minnesota; Alaska Native...CompletedPregnancy | Nicotine DependenceUnited States
-
Changhai HospitalCompletedPancreatitis, ChronicChina
-
Pontificia Universidad Catolica de ChileCompletedSmoking CessationChile
-
Butler HospitalNational Institute on Drug Abuse (NIDA)Completed
-
University of SalernoNot yet recruitingSmoking Cessation | Smoking Behaviors | Smoking Dependence | Smoking Abstinence | Smoking Cessation Intervention | Smoking (Tobacco) Addiction | Smoking E-cigarette | Smoking Addiction | Smoking ( Cigarette)
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Kaohsiung Veterans General Hospital.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCurrent Every Day Smoker | Cigarette SmokerUnited States
-
Riphah International UniversityCompletedCoronary Heart DiseasePakistan
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States